Cellectar Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $38,960,643.

Profit Margin

Cellectar Biosciences, Inc. (NASDAQ:CLRB): Profit margin
2014 0 -8.10M
2015 0 -5.49M
2016 0 -6.18M
2017 0 -13.56M
2018 0 -13.23M
2019 0 -13.87M
2020 0 -14.75M
2021 0 -23.97M
2022 0 -28.60M
2023 0 -37.98M

CLRB Income Statement (2014 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
192.37K238.86K227.63K207.92K189.36K82.26K1.54M356.66K362.50K0
Gross profit
-192.37K-238.86K-227.63K-207.92K-189.36K-82.26K-1.54M-356.66K-362.50K0
Operating exp.
Research and development
27.26M19.21M17.58M10.14M8.99M6.83M9.46M4.75M5.15M5.96M
Selling and marketing
945.18K000000000
Total operating expenses
38.96M28.81M24.13M15.29M14.17M11.65M13.60M9.44M8.55M9.66M
Operating income
-38.96M-28.81M-24.13M-15.29M-14.17M-13.33M-13.60M-9.44M-8.75M-9.89M
Other income (expenses), net
917.14K152.51K8.91K196.17K85.71K-1.61M38.68K3.26M3.26M1.78M
Income before tax
-38.04M-28.66M-24.12M-15.09M-14.09M-13.23M-13.56M-6.18M-5.49M-8.10M
Income tax expense
-60K-60K-152.19K-337.63K-218.51K-1.55M-38.68K-3.26M-3.42M-1.56M
Net income
-37.98M-28.60M-23.97M-14.75M-13.87M-13.23M-13.56M-6.18M-5.49M-8.10M
Earnings per share
Basic EPS
-3.11-4.05-4.32-7.45-18.08-44.7-96.66-141.54-702.78-1.76K
Diluted EPS
-3.11-4.05-4.32-7.45-18.08-44.7-96.66-141.54-702.78-1.76K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source